Business description
Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications though its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.
Management board & Supervisory board
| CEO |
| Blaise Coleman |
| Management board |
| Mark Bradley, Dr. James P. Tursi, George Apostol, M.D., James Papp, Joseph A. Barbarite, Laure Park, Matthew J. Maletta, Patrick Barry, Robert Polke, Ruth Thorpe, Susan Williamson, Tracy Basso |
| Supervisory board |
| Mark G. Barberio, Blaise Coleman, Dr. M. Christine Smith, Dr. Nancy J. Hutson, Jennifer M. Chao, Michael Hyatt, Shane M. Cooke, William P. Montague |
Company data
| Name: |
Endo International Plc. |
| Address: |
First Floor, Minerva House, Simmonscourt Road,Ballsbridge, Dublin 4, Ireland |
| Phone: |
+11-353-1-268-200 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
www.endo.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
57.10% |
| IPO date: |
- |
